Panaroma Next-generation NIPT: Natera

*REFERENCES:

1. Nicolaides et al. Prenat Diagn. 2013 June; 33(6):575-9.

2. Pergament et al. Obstet Gynecol. 2014 Aug; 124(2 Pt 1):210-8.

3. Ryan et al. Fetal Diagn Ther. 2016;40(3):219-223.

4. Norvez et al. The European Human Genetics Conference, ESHG. Copenhagen, Denmark. May 27–30, 2017.

5. Stokowski et al. Prenat Diagn. 2015 Dec; 35(12):1243-6.

6. Schmid et al. Fetal Diagn Ther. 2017, DOI: 10.1159/000484317.

7. Palomaki et al. Genet Med. 2011 Nov; 13(11):913-20.

8. Palomaki et al. Genet Med. 2012 Mar; 14(3):296-305.

9. Porreco et al. Am J Obstet Gynecol 2014;211:365.e1-12.

10. Tynan et al. Society for Maternal-Fetal Medicine, SMFM. Las Vegas, Nevada. Jan 23-28, 2017.

11. Sehnert et al. Clinical Chemistry 2011 Jun;57(7):1042–1049.

12. Bianchi et al. Obstet Gynecol. 2012 May; 119(5):890-901.

13. Bianchi et al. N Engl J Med 2014;370:799-808.

14. Commercial protocol not validated; Illumina marketing materials cite “Srinivasan et al. Am J Hum Genet. 2013 Feb 7; 92(2): 167–176” which does not match number of reads used in commercial testing.

15. Jones et al. Ultrasound Obstet Gynecol. 2018 Feb;51(2):275-276.

16. Mazloom et al. Prenat Diagn 2013 Jun; 33(6):591-7.

17. Verinata white paper. Analytical validation of the Verifi prenatal test. 2012.

The test described has been developed and its performance characteristics determined by the CLIA-certified laboratory performing the test. The test has not been cleared or approved by the US Food and Drug Administration (FDA). Although FDA has generally not enforced the premarket review and other FDA legal requirements for laboratory-developed tests in the US, certification of the laboratory is required under CLIA to ensure the quality and validity of the tests. © 2020 Natera, Inc. All Rights Reserved.

Thank you

Over 2 Million

Most Accurate NIPT

Panorama uniquely uses differences between mom and child's DNA to help deliver highly accurate results to patients.